Bajaj Holdings & Investment has amended its ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’. The board approved these changes at a meeting held on September 16, 2025. The amended code ensures transparency and proper handling of sensitive information within the company. This aligns with regulatory requirements for fair disclosures.

Amendment to Disclosure Code

Bajaj Holdings & Investment has announced an amendment to its ‘Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information’ (the ‘Code’). The announcement was made on September 16, 2025.

Details of the Amendment

The amendment follows the guidelines for fair disclosure. The amended code has been posted on the company’s website for stakeholders.

Key Points of the Amended Code:

Legitimate Purposes: The term includes sharing UPSI in the ordinary course of business with various parties, provided it doesn’t evade prohibitions.

UPSI Definition: As defined under relevant regulations and the Company’s Code of Conduct.

Prompt Disclosure: Ensuring prompt public disclosure of UPSI impacting price discovery.

Uniform Dissemination: Ensuring uniform dissemination of UPSI to avoid selective disclosure.

CIRO Role: The Compliance Officer acts as the Chief Investor Relations Officer (CIRO).

Handling Queries: Ensuring appropriate and fair responses to news reports and market rumors.

Analyst Information: Ensuring shared information with analysts isn’t UPSI.

Record Keeping: Maintaining records of analyst interactions and investor conferences.

Need-to-Know Basis: Handling all UPSI on a need-to-know basis.

Insider Definition: Persons receiving UPSI for a “legitimate purpose” are considered “insiders.”

Digital Database: A structured digital database is maintained with details of those with whom UPSI is shared.

Policy for Legitimate Purposes

Principles: Including authority to seek/provide information, disclosed purpose, necessity, timeliness, conditions, regulatory compliance, consistency, and not being for trading.

Deemed Legitimate: Sharing financial data with auditors, complying with investigations, and adhering to court orders.

Compliance: Aligning with laws, regulations, and contractual obligations.

Process for Sharing UPSI

Satisfying information is UPSI, identifying recipients, notifying recipients of confidentiality, and choosing the appropriate mode of sharing.

Database Maintenance

Maintaining structured databases with necessary identifiers and controls to prevent tampering.

Policy Review

The Policy shall be reviewed periodically for regulatory requirements. Provisions of law shall override this policy.

Source: BSE

Dr. Reddy’s Laboratories has launched Tegoprazan, a novel patented molecule, in India for acid-related gastrointestinal diseases under the brand name PCAB®. This launch follows an exclusive partnership with HK inno.N Corporation. Tegoprazan, a next-generation potassium-competitive acid blocker, addresses a critical need in acid peptic disease management. It has already been approved in 21 countries and has completed Phase-III trials in the United States.

Tegoprazan Launch in India

Dr. Reddy’s Laboratories has announced the launch of its novel molecule, Tegoprazan, in India, indicated for acid-related gastrointestinal diseases. The drug will be marketed under the brand name PCAB®.

About Tegoprazan

Tegoprazan is a next-generation potassium-competitive acid blocker used to treat acid peptic diseases (APD) such as Erosive Gastroesophageal Reflux Disease (GERD), Non-Erosive Gastroesophageal Reflux Disease (NERD), and Gastric Ulcer. It offers fast action and prolonged gastric pH control, benefiting APD management.

Impact on the Market

With approximately 38% of the Indian population affected by APD, Tegoprazan’s launch addresses a significant need for effective management strategies. Clinical trials have shown promising results, including 99% endoscopic healing in GERD patients within 8 weeks in a multinational trial across India, South Africa, and Russia.

Executive Commentary

M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets) at Dr. Reddy’s, stated that the launch reinforces the company’s commitment to innovation in gastrointestinal disease treatment. Dal-Won Kwak, Chief Executive Officer at HK inno.N Corporation, expressed honor in introducing Tegoprazan to the Indian market, hoping it will become a leading therapy in its class.

Global Presence

Tegoprazan has already been approved in 21 countries, including South Korea and China, and is currently under registration in several other countries. It has also successfully completed Phase-III trials in the United States, indicating a broad potential market reach.

Source: BSE

Nestlé India has announced an upcoming one-on-one virtual meeting with an institutional investor, scheduled for September 23, 2025, at 3:30 P.M. (IST). The company will likely provide updates on its performance, strategy, and outlook. This meeting offers an opportunity for the investor to gain deeper insights into Nestlé India’s operations and future plans, potentially influencing investment decisions.

Investor Engagement Announcement

Nestlé India has formally scheduled a virtual, one-on-one meeting with an institutional investor. The meeting is set to take place on Tuesday, September 23rd, 2025.

Meeting Details

The virtual interaction is scheduled for 3:30 P.M. (IST). The company has released this information to keep the market informed about its investor relations activities. Further details about the discussion topics are not disclosed in the announcement.

Source: BSE

Engineers India Limited (EIL) has announced the appointment of M/s Datta Singla & Co., Chartered Accountants, as the Statutory Auditors for the financial year 2025-26. The appointment follows the consent received on September 16, 2025, and is made under Section 139 of the Companies Act, 2013. M/s Datta Singla & Co., established in 1970, is empaneled with CAG and RBI.

Statutory Auditor Appointment

Engineers India Limited (EIL) confirms the appointment of M/s Datta Singla & Co. as the Statutory Auditors of the company for the financial year 2025-26. The appointment, effective from September 16, 2025, ensures compliance with regulatory requirements for independent financial oversight.

Auditor Profile

M/s Datta Singla & Co., a Chartered Accountancy firm, was established in 1970 and is empaneled with the Comptroller & Auditor General (CAG) and the Reserve Bank of India (RBI). The appointment leverages the firm’s extensive experience in auditing and financial oversight.

Appointment Details

The appointment of M/s Datta Singla & Co. is made under Section 139 of the Companies Act, 2013, and stems from authorization received via letter dated November 9, 2025.

Enclosures

The appointment includes enclosures detailing the terms of the appointment and consent letter from M/s Datta Singla & Co.

Source: BSE

Bharat Electronics Limited (BEL) has announced that it has secured additional orders worth ₹712 Crore since September 1, 2025. These new orders encompass a diverse range of solutions and equipment, further strengthening the company’s position in the defense and electronics sector.

New Order Details

Bharat Electronics Limited (BEL) has successfully secured additional orders amounting to ₹712 Crore. These orders were received after the last disclosure made on September 1, 2025.

Scope of the Orders

The newly acquired orders span several key areas, including:

• IT Infrastructure & Cyber Security Solutions
• ESM (Electronic Support Measures) Systems
• Block Chain Solution Platform
• Communication Equipment
• Spares
• Services

These orders highlight BEL’s diverse capabilities and its continued success in securing significant projects across various sectors.

Source: BSE

Bharat Dynamics Limited (BDL) has reappointed M/s Tej Raj & Pal, Chartered Accountants, as its Statutory Auditors for the financial year 2025-26. The appointment follows the approval from the Comptroller & Auditor General of India. M/s Tej Raj & Pal bring extensive experience and expertise to ensure compliance and financial integrity for BDL.

Auditor Appointment Confirmed

Bharat Dynamics Limited has officially appointed M/s Tej Raj & Pal, Chartered Accountants, as the company’s statutory auditor. This decision is for the financial year 2025-26. The appointment was confirmed following the letter from the Comptroller & Auditor General of India dated 10 September 2025.

About the Statutory Auditor

M/s Tej Raj & Pal is described as having a strong team comprised of experienced partners and qualified Chartered Accountants, as well as Cost Management Accountants, financial experts, and IT & Legal Experts. They are noted for their understanding of accounting standards and providing industry-specific solutions.

Appointment Details

The appointment of M/s Tej Raj & Pal is a reappointment for the financial year 2025-26, which will help ensure compliance and strong financial auditing practices at Bharat Dynamics Limited.

Source: BSE

Blue Dart Aviation Limited, a wholly-owned subsidiary of Blue Dart Express, has received a Show Cause Cum Demand Notice (SCN) from the Office of the Commissioner of GST and Central Excise on September 15, 2025. The notice pertains to alleged tax dues for the period from April 2021 to March 2023.

GST Demand Notice Details

Blue Dart Aviation Limited (BDAL), a wholly-owned subsidiary of Blue Dart Express, has received a Show Cause Cum Demand Notice (SCN) regarding alleged tax dues. The notice was received on September 15, 2025, from the Office of the Commissioner of GST and Central Excise.

Period and Allegations

The SCN alleges demand and recovery of tax dues under Section 73(1) of the CGST Act, 2017/TNGST Act, 2017, for the period covering April 2021 to March 2023. BDAL is required to respond to the Additional/Joint Commissioner of GST & Central Excise within 30 days of receiving the notice.

Specific Issues Raised

The notice identifies several issues, including:

• GST paid under the wrong head (IGST instead of CGST & SGST) amounting to Rs.365,58,01,534.
• Potentially ineligible Input Tax Credit (ITC) availed on invoices issued by other locations totaling Rs. 54,55,87,027.
• ITC/CENVAT credit involved in materials subsequently written off, amounting to Rs.64,98,000.

Company’s Response

Blue Dart is currently evaluating the matter and will submit its reply within the prescribed timeframe. At this stage, the company does not anticipate any significant impact on its financials, operations, or other activities.

Source: BSE